lazard held a conference call yesterday with a user of Bluebelt's NavioPFS (new competitor Mako's Rio).
"Positive opinion on the NavioPFS system. The doc was positive overall on the NavioPFS system, citing the lack of preparation time and CT scan as a key competitive advantage to the Rio system, giving the doctor the ability to intuitively work through the operation with a touch screen so the doc can navigate and plan as the surgery proceeds. Another advantage over MAKO the doc mentioned was the price, with the NavioPFS system costing him $80K-$100K (likely lower price as an early adopter, we anticipate ASP of $300K-$350K) compared to the Rio at close to $1M. He liked Navio's open architecture currently allowing a variety of different company implants."
So lazard has an investment in that company and is preping them to go public I take it, I read about that system, I think it has done all of four surgeries or something, I guess MAKO has done 20,000. Lennox Hospital Just bought a 1.2 million dollar system, and I.m sure they had an opprotunity to buy the other, they chose MAKO.
It looks like it reached the top of the range of 12.30 and that seems to be the reason, based upon the sales fiqures and the genral disgust of the stock right now I would say it is a good investement, as a trade perhaps.